Federated Hermes, Inc. Fibrogen Inc Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.49 - $20.59 $123,892 - $1.02 Million	-49,756 Reduced 78.16%	13,901 $37,000
Q1 2023 May 08, 2023	BUY	$15.95 - $25.18 $680,682 - $1.07 Million	42,676 Added 203.4%	63,657 $1.19 Million
Q4 2022 Feb 13, 2023	SELL	$13.27 - $17.73 $1.26 Million - $1.68 Million	-94,878 Reduced 81.89%	20,981 $336,000
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $9.82 Million - $12.6 Million	-861,742 Reduced 88.15%	115,859 $1.51 Million
Q2 2022 Aug 15, 2022	SELL	$7.94 - $12.96 $11.3 Million - $18.4 Million	-1,418,282 Reduced 59.2%	977,601 $10.3 Million
Q1 2022 May 13, 2022	BUY	$12.02 - $16.79 $13.2 Million - $18.4 Million	1,094,403 Added 84.09%	2,395,883 $28.8 Million
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $7.77 Million - $12 Million	782,828 Added 150.94%	1,301,480 $18.4 Million
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $5.28 Million - $13.8 Million	518,652 New	518,652 $5.3 Million
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $1.24 Million - $2.37 Million	-66,509 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$31.0 - $55.72 $330,987 - $594,922	-10,677 Reduced 13.83%	66,509 $2.31 Million
Q4 2020 Feb 12, 2021	BUY	$37.09 - $48.97 $290,006 - $382,896	7,819 Added 11.27%	77,186 $2.86 Million
Q3 2020 Nov 12, 2020	BUY	$40.47 - $45.5 $2.81 Million - $3.16 Million	69,367 New	69,367 $2.85 Million
Q2 2020 Aug 13, 2020	SELL	$32.57 - $42.83 $358 - $471	-11 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$23.3 - $45.96 $256 - $505	11 New	11 $1,000
Q3 2019 Nov 14, 2019	SELL	$36.98 - $48.45 $961 - $1,259	-26 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $1.64 Million - $2.59 Million	-46,615 Reduced 99.94%	26 $1,000
Q1 2019 May 10, 2019	BUY	$42.83 - $59.91 $1.82 Million - $2.54 Million	42,383 Added 995.37%	46,641 $2.54 Million
Q3 2018 Nov 13, 2018	SELL	$56.3 - $67.25 $1.21 Million - $1.45 Million	-21,567 Reduced 83.51%	4,258 $259,000
Q2 2018 Aug 10, 2018	BUY	$44.9 - $64.95 $1.12 Million - $1.63 Million	25,045 Added 3210.9%	25,825 $1.62 Million
Q1 2018 May 09, 2018	SELL	$45.35 - $61.65 $32,833 - $44,634	-724 Reduced 48.14%	780 $36,000
Q4 2017 Feb 14, 2018	SELL	$41.95 - $60.1 $1.09 Million - $1.56 Million	-25,925 Reduced 94.52%	1,504 $0
Q3 2017 Nov 13, 2017	BUY	$33.4 - $53.9 $916,128 - $1.48 Million	27,429	27,429 $1.48 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account